In summary, a growing body of evidence highlights the importance of IR-A and IGF-IR in regulating stem cell biology, and supports the notion that IGF-I levels in the newborn are positively related to the total number of stem cells, which is associated with the risk of future cancers (19). This evidence concerns the gene IGF1 and cancer.